|Articles|May 1, 2003
MAL-PDT Tx of BCC
Author(s)Barbara J. Rutledge, PhD
San Francisco - Photodynamic therapy (PDT) using methyl aminolevulinate (MAL) as a photosensitizer is as safe and effective as cryotherapy for treatment of primary superficial basal cell carcinoma (sBCC), according to Nicole Basset-Seguin, M.D., professor of dermatology, H~4al Saint-Louis, Paris.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5














